, Worldwide increasing risk factors for leishmaniasis, Medical Microbiology and Immunology, vol.190, issue.1-2, pp.77-79, 2001.
DOI : 10.1007/s004300100085
, Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran, Acta Tropica, vol.103, issue.1, pp.33-40, 2007.
DOI : 10.1016/j.actatropica.2007.05.005
, Identification of Leishmania species isolated from human cutaneous Leishmaniasis, using RAPD-PCR, Iranian Journal of Public Health, vol.33, pp.8-15, 2004.
, Leishmaniasis: new approaches to disease control, BMJ, vol.326, issue.7385, pp.377-382, 2003.
DOI : 10.1136/bmj.326.7385.377
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125241
, Resistance to antimony and treatment failure in human Leishmania (Viannia) infection, Journal of Infectious Diseases, vol.15, pp.1375-1383, 2006.
, Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites, PLoS Medicine, vol.29, issue.5, p.162, 2006.
DOI : 10.1371/journal.pmed.0030162.sd002
, In vitro and in vivo models for the identification and evaluation of drugs active against Trypanosoma and Leishmania, Drugs against parasitic diseases: R&D methodologies and issues, pp.165-175, 2003.
, Chemotherapy in the Treatment and Control of Leishmaniasis, Advances in Parasitology, vol.61, pp.223-274, 2006.
DOI : 10.1016/S0065-308X(05)61006-8
, Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro, American Journal of Tropical Medicine and Hygiene, pp.31459-465, 1982.
, Sodium stibogluconate (Pentostam ) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes, Biochemical Pharmacology, vol.36, pp.197-201, 1987.
, A member of the aldoketo reductase family confers methotrexate resistance in Leishmania, Journal of Biological Chemistry, vol.267, pp.24165-24168, 1992.
, A novel antifolate resistance gene on the amplified H circle of Leishmania, EMBO Journal, vol.11, pp.3601-3608, 1992.
, Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-126, 2006.
DOI : 10.1128/CMR.19.1.111-126.2006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360270
, Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays, Nucleic Acids Research, vol.31, issue.20, pp.5886-5896, 2003.
DOI : 10.1093/nar/gkg806
, A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death, Molecular & Cellular Proteomics, vol.6, issue.1, pp.88-101, 2007.
DOI : 10.1074/mcp.M600319-MCP200
URL : https://hal.archives-ouvertes.fr/hal-00170702
, Protein profiling on meglumine antimoniate (glucantime (r)) sensitive and resistant L. tropica isolates by 2-dimentional gel electrophoresis: a preliminary study, Iranian Journal of Parasitology, vol.4, pp.8-14, 2009.
, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3
, Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels, Analytical Chemistry, vol.68, issue.5, pp.850-858, 1996.
DOI : 10.1021/ac950914h
, Proteomics to explore pathogenesis and drug resistance mechanisms in protozoan parasites Biomedical and pharmaceutical applications of proteomics, 2004.
, Differential Protein Expression Analysis of Leishmania major Reveals Novel Roles for Methionine Adenosyltransferase and S-Adenosylmethionine in Methotrexate Resistance, Journal of Biological Chemistry, vol.279, issue.32, pp.33273-33280, 2004.
DOI : 10.1074/jbc.M405183200
, A proteomic approach to identify developmentally regulated proteins in Leishmania infantum, PROTEOMICS, vol.2, issue.8, pp.1007-1017, 2002.
DOI : 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G
, Establishing two-dimensional gels for the analysis of Leishmania proteomes, PROTEOMICS, vol.2, issue.7, pp.877-879, 2002.
DOI : 10.1002/1615-9861(200207)2:7<877::AID-PROT877>3.0.CO;2-D
, A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major, Vaccine, vol.22, issue.13-14, pp.1631-1639, 2004.
DOI : 10.1016/j.vaccine.2003.10.046
, Leishmania major LACK antigen is required for efficient vertebrate parasitization, Journal of Experimental Medicine, issue.11, pp.1981689-1698, 2003.
DOI : 10.1084/jem.20031162
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194132
, Molecular mechanisms of antimony resistance in Leishmania, Journal of Medical Microbiology, vol.56, issue.2, pp.143-153, 2007.
DOI : 10.1099/jmm.0.46841-0
, Modulation of Leishmania ABC Protein Gene Expression through Life Stages and among Drug-Resistant Parasites, Eukaryotic Cell, vol.5, issue.10, pp.1713-1725, 2006.
DOI : 10.1128/EC.00152-06
, Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, Journal of Clinical Investigation, vol.103, issue.3, pp.393-399, 1999.
DOI : 10.1172/JCI4890
, Prostaglandin production from arachidonic acid and evidence for a 9,11-endoperoxide prostaglandin H2 reductase in Leishmania, International Journal for Parasitology, vol.32, issue.14, pp.1693-1700, 2002.
DOI : 10.1016/S0020-7519(02)00160-1
, Proteome Mapping of the Protozoan Parasite Leishmania and Application to the Study of Drug Targets and Resistance Mechanisms, Molecular & Cellular Proteomics, vol.2, issue.3, pp.146-155, 2003.
DOI : 10.1074/mcp.M200085-MCP200